Nano Dimension (NNDM) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
25 Jun, 2026Executive summary
An extraordinary general meeting is scheduled for July 31, 2026, following a demand by a group of significant shareholders to address governance and strategic direction.
The agenda includes proposals from both the board and the proposing shareholders, with the board recommending support for only two of six proposals.
The board urges shareholders to vote using the official proxy card and disregard materials from the proposing shareholders.
Voting eligibility is set for shareholders of record as of June 23, 2026, with detailed procedures for both ordinary and ADS holders.
Proxy solicitation is contested, with significant additional costs anticipated due to the nature of the meeting.
Voting matters and shareholder proposals
Proposal 1: Non-binding advisory vote on continuing the strategic alternatives review process; board recommends FOR.
Proposal 2: Amend Article 39 to declassify the board; board recommends FOR.
Proposal 3: Add Article 71 requiring shareholder approval for rights plans; board recommends AGAINST.
Proposal 4: Add Article 72 requiring shareholder approval for major transactions; board recommends AGAINST.
Proposal 5: Remove three current directors; board recommends AGAINST.
Proposal 6: Elect three new directors if Proposal 5 passes; board recommends AGAINST.
Board of directors and corporate governance
The board currently consists of experienced professionals in technology, finance, and law.
Proposing shareholders seek to declassify the board and replace three directors with their nominees.
Biographical details for both current and proposed directors are provided.
Board recommends against changes that would add new Articles 71 and 72 or replace directors.
Latest events from Nano Dimension
- Proxy contest aims to declassify the board, restrict poison pills, and replace key directors.NNDM
Proxy filing18 Jun 2026 - Proposed merger with Infinite Epigenetics offers a 20% premium and pivots to AI-powered diagnostics.NNDM
Proxy filing17 Jun 2026 - $890M merger forms a Nasdaq-listed AI diagnostics leader targeting the $90–94B U.S. market.NNDM
M&A announcement16 Jun 2026 - Nano and Infinite plan a merger to create an AI-powered health diagnostics company, pending approvals.NNDM
Proxy filing15 Jun 2026 - Board supports declassification but opposes director removal and other governance changes.NNDM
Proxy filing11 Jun 2026 - Shareholders will vote on strategic direction, board structure, and director changes amid a proxy contest.NNDM
Proxy filing5 Jun 2026 - Strategic plan advances with cost cuts, asset sales, and a pivotal shareholder vote ahead.NNDM
Proxy filing5 Jun 2026 - Board opposes activist director replacements, prioritizing strategic review and shareholder value.NNDM
Proxy filing26 May 2026 - Q1 2026 revenue surged 106% year-over-year, but net loss deepened amid restructuring and impairment.NNDM
Q1 20267 May 2026